Virax Biolabs Group Ltd (VRAX)
1.16
-0.02
(-1.69%)
USD |
NASDAQ |
Jun 28, 16:00
1.15
-0.01
(-0.86%)
After-Hours: 20:00
Virax Biolabs Group Market Cap: 2.101M for June 28, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| June 28, 2024 | 2.101M |
| June 27, 2024 | 2.138M |
| June 26, 2024 | 2.228M |
| June 25, 2024 | 2.409M |
| June 24, 2024 | 2.337M |
| June 21, 2024 | 2.717M |
| June 20, 2024 | 3.116M |
| June 18, 2024 | 3.116M |
| June 17, 2024 | 3.116M |
| June 14, 2024 | 3.279M |
| June 13, 2024 | 3.134M |
| June 12, 2024 | 3.043M |
| June 11, 2024 | 2.971M |
| June 10, 2024 | 3.496M |
| June 07, 2024 | 3.569M |
| June 06, 2024 | 3.569M |
| June 05, 2024 | 1.938M |
| June 04, 2024 | 1.902M |
| June 03, 2024 | 1.884M |
| May 31, 2024 | 2.138M |
| May 30, 2024 | 1.974M |
| May 29, 2024 | 1.667M |
| May 28, 2024 | 1.612M |
| May 24, 2024 | 1.630M |
| May 23, 2024 | 1.509M |
| Date | Value |
|---|---|
| May 22, 2024 | 1.549M |
| May 21, 2024 | 1.433M |
| May 20, 2024 | 1.504M |
| May 17, 2024 | 1.521M |
| May 16, 2024 | 1.420M |
| May 15, 2024 | 1.422M |
| May 14, 2024 | 1.368M |
| May 13, 2024 | 1.437M |
| May 10, 2024 | 1.449M |
| May 09, 2024 | 1.250M |
| May 08, 2024 | 1.375M |
| May 07, 2024 | 1.322M |
| May 06, 2024 | 1.136M |
| May 03, 2024 | 1.112M |
| May 02, 2024 | 1.105M |
| May 01, 2024 | 1.176M |
| April 30, 2024 | 1.141M |
| April 29, 2024 | 1.139M |
| April 26, 2024 | 1.25M |
| April 25, 2024 | 1.268M |
| April 24, 2024 | 1.202M |
| April 23, 2024 | 1.192M |
| April 22, 2024 | 1.277M |
| April 19, 2024 | 1.227M |
| April 18, 2024 | 1.231M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.105M
Minimum
May 02 2024
236.58M
Maximum
Jul 28 2022
14.16M
Average
6.600M
Median
Market Cap Benchmarks
| Barinthus Biotherapeutics PLC | 54.65M |
| Adaptimmune Therapeutics PLC | 248.48M |
| Biodexa Pharmaceuticals Plc | 8.124M |
| Verona Pharma PLC | 1.172B |
| NuCana PLC | 5.779M |
Market Cap Related Metrics
| Price | 1.16 |